News & Events
Using Customer Data, 23andMe Plans to Invent its Own Drugs
23andMe, a DNA analysis service company who provides information and tools to individuals to learn more about their DNA has announced its plan to invent its own drugs using customer data. This drastic move will allow 23andMe to capitalize on the economic value its...
Complying with clinical trial requirements takes 23 million hours per year
Conducting clinical research is extremely time consuming given the extensive requirements necessary to begin a clinical trial. Protocols must be adhered to, results must be extensively recorded, and most importantly, patients must be protected complying with Section...
Heidi Strunk to present on Inspection Readiness at IMDMC workshop on April 15th
Pearl Pathways’ own, Heidi Strunk, RAC will be presenting at the Indiana Medical Device Manufacturers Council (IMDMC) workshop in Indianapolis, Indiana entitled, A Deep Dive Into Inspection Preparedness. The workshop provides an opportunity to hear from experts who...
Pearl IRB’s uniqueness further distinguished with AAHRPP Accreditation
Pearl IRB joins an elite group of 23 commercial-independent IRBS’s and becomes just the second AAHRPP accredited organization in the state of Indiana by demonstrating high standards of excellence for quality, ethics, and protection in all levels of research. Pearl...
Gretchen Bowker to hold webinar via ComplianceOnline on March 19th
Pearl Pathways’ own COO and Co-Founder, Gretchen Bowker will be holding a webinar on FDA regulatory requirements for the manufacturing and commercialization of dietary supplements via ComplianceOnline. A few of the topics include a review of FDA regulations in the...